Tenofovir AF + Emtricitabine

Form: Tablet

Strength: Tenofovir AF 25 mg + Emtricitabine 200 mg

Reference Brands: Descovy(EU & US)

Category: Anti Viral

Tenofovir Alafenamide (TAF) + Emtricitabine is a modern, once-daily antiretroviral combination used for the treatment and prevention of HIV-1 infection. Marketed under the brand name Descovy, this formulation offers a safer alternative to TDF-based regimens, with improved renal and bone safety. TAF is a prodrug of tenofovir, delivering effective viral suppression at a lower dose. Combined with Emtricitabine, an NRTI, it forms the backbone of several HIV therapies like Biktarvy, Genvoya, and Odefsey. Approved by the FDA and EMA, TAF + Emtricitabine is also used in PrEP to reduce the risk of HIV transmission in high-risk populations.